MSB 7.69% $1.19 mesoblast limited

MSB Trading - 2020, page-21443

  1. 2,709 Posts.
    lightbulb Created with Sketch. 168
    Be an interesting report that I have missed a link would be good as I have only:

    Financial Highlights for the Nine Months of FY2020 Compared with the Nine
    Months of FY2019:
    • 113% increase in revenues to US$31.5 million, compared with US$14.8 million, comprising:
    o 81% growth in royalty revenues to US$5.9 million from sales of TEMCELL HS Inj.®1 by
    Mesoblast’s licensee for steroid-refractory acute graft versus host disease (SR-aGVHD)
    in Japan, compared with US$3.3 million.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.